Navigation Links
Results From Phase II Trial in Critical Care Medicine Showed Eritoran Tetrasodium (E5564) To Be Well Tolerated in Patients with Severe Sepsis
Date:12/22/2009

x days) and 94 patients received eritoran high-dose (105mg given every 12 hours for six days). Seven patients did not receive any trial drug and were not included in the modified intent to treat population for analysis. Eritoran or placebo doses were administered via intravenous infusion within 12 hours of recognition of severe sepsis and repeated every 12 hours for six days.

In this Phase II trial, eritoran was well tolerated, and the following adverse events were found:

Anemia, diarrhea, insomnia, acute renal failure and rash were observed more frequently in the group receiving eritoran compared to the group receiving placebo, although not statistically significant.

Serious adverse events that occurred in greater than 5% of patients in both the eritoran and placebo treated groups included cardiac arrest, multiorgan failure, sepsis, respiratory failure and deep vein thrombosis.

Four patients in the group receiving eritoran experienced a hepatobiliary serious adverse event compared with none in the group receiving placebo. Three of these four subjects had pre-existing liver disease.

A higher incidence of atrial fibrillation seen in the eritoran high-dose group (12.8%) compared to placebo (7.3%) was not statistically significant. Instances were mild or moderate in severity and it was unclear if the increased incidence is related to eritoran administration.

Phlebitis (inflammation of the vein) was observed in 6.7% of patients dosed with eritoran high-dose through a peripheral vein (versus 1.6% through central line); affected subjects recovered. No patient in the group receiving placebo experienced phlebitis.

The occurrence of infectious complications reported as adverse events by trial investigators did not differ notably among the three groups.

The mortality in the placebo, low-dose and high-dose groups was 33.3%, 32% and 26.6% respectively. Although not statistically signific
'/>"/>

SOURCE Eisai
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders
2. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
3. American Imaging Managements New Specialty Drug Program Delivers Immediate Results
4. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
5. BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronies Disease
6. Immucor to Announce Fiscal Second Quarter Financial Results on Wednesday, January 6, 2010
7. Robbins & Myers To Release First Quarter Fiscal 2010 Financial Results
8. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
9. AVAC Says MDP 301 Microbicide Trial Results Disappointing, but Researchers and 9,400 Trial Volunteers Deserve Praise for Successful Trial
10. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
11. Neogen Corporation Announces 2nd Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , Kalifornien, 20. Mai 2013 ... das Unternehmen die CE-Kennzeichnung für die SL-Produktfamilie ... von Aneurysmen erhalten hat. Das Unternehmen hat ... mit der kontrollierten Einführung dieser neuen Modelle ... SL-Produktfamilie auch ein verbessertes Handling, das es ...
(Date:5/20/2013)... DIEGO , May 20, 2013 Enrollment ... Elcelyx Therapeutics, Phase 2b dose-finding clinical trial of product ... metformin, the foundational treatment for Type 2 diabetes. Elcelyx ... multicenter U.S. program in June. Results of the trial,s ... expected in late summer, and the read-out for long-term ...
(Date:5/20/2013)... , May 20, 2013  AbbVie (NYSE: ... of a Phase 3 clinical study called SONAR ... the effects of the investigational compound atrasentan - when ... kidney disease in patients with stage 2 to ... diabetes.  SONAR is a large, multinational, double-blind, placebo-controlled ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6
... NATICK, Mass., Jan. 4, 2011 Boston Scientific Corporation ... of its acquisition of Sadra Medical, Inc. of Los ... announced on November 19, 2010.  Under the terms of ... the remaining 86 percent of Sadra Medical,s equity not ...
... and Company) (NYSE: BDX ), a leading global medical ... Annual J. P. Morgan Healthcare Conference on Monday, January 10, 2011, ... BD,s presentation can be accessed from the BD corporate website at ... January 17, 2011.   About BDBD is ...
Cached Medicine Technology:Boston Scientific Completes Acquisition of Sadra Medical 2Boston Scientific Completes Acquisition of Sadra Medical 3Boston Scientific Completes Acquisition of Sadra Medical 4
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 Today, ... assistant at HealthBeat 2013. A mobile application called Allie ... time and effort it takes to arrange for quality ... offers a unique combination of mobile technology and access ... to help people ensure their health care needs are ...
(Date:5/20/2013)... It’s May which means it’s Bike Month! If you ... those dusty bikes and helmets. , Windsong Production's and BLARE ... the office with Windsong Productions challenging BLARE ... miles for the 4th Annual Million Mile Challenge. They may ... *insert battle prep montage* , This is all part of ...
(Date:5/20/2013)... Santa Rosa, CA (PRWEB) May 20, 2013 ... Population Health and Business Intelligence solutions, i2i ... Baldrige National Quality Award-winning Southcentral Foundation (SCF) selected ... utilize i2iTracks to help them meet their Meaningful ... and Uniform Data System (UDS) requirements – a ...
(Date:5/20/2013)... Las Vegas, NV (PRWEB) May 20, 2013 ... Health IT to improve the exchange of healthcare information, ... the creation of the WEDI ICD-10 State Collaborative ... organizations and their members in order to increase efficiencies ... ICD-10 compliance. , The goal of the new initiative ...
(Date:5/20/2013)... A new Canadian study has uncovered an apparent gender ... than men to get trauma center care following a ... care services in general have been recognized for some ... to the treatment of severe injuries in trauma centers," ... Health Sciences Centre and the University of Toronto, said ...
Breaking Medicine News(10 mins):Health News:Allayo Debuts Virtual Health Assistant At HealthBeat 2013 2Health News:Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements 2Health News:Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements 3Health News:WEDI Launches New ICD-10 State Collaborative Initiative to Increase Efficiencies and Reduce Compliance Time and Costs 2Health News:Women Less Likely to Get Trauma Center Care After Injury: Study 2
... ... New book - ,Public Health 101, - by Richard K. Riegelman, ... for an undergraduate course by the same name. The book is an ... that view an understanding of public health issues as a critical component ...
... Aug. 1 issue of the journal SLEEP indicates ... apnea (OSA) if they have at least one sibling who ... that after accounting for socioeconomic status, age, and geographic region, ... a standardized incidence ratio of 33.2 in boys and 40.5 ...
... WASHINGTON, July 31 Pharmaceutical Research and Manufacturers of America ... after the Energy and Commerce Committee mark-up of the House ... to working with the Administration and Congress to help enact ... with the White House and the Senate Finance Committee, which ...
... WASHINGTON, July 31 Speaker Nancy Pelosi issued the ... Commerce Committee to pass the America,s Affordable Health Choices Act, the ... House Ways and Means Committee and Education and Labor Committee approved ... "For more than 60 years, we have tried as a nation ...
... , WASHINGTON, July 31 ... "The Importance of a Cost Control Enforcement Entity In ... President Obama,s proposed Independent Medicare Advisory Council (IMAC). The ... experts who would routinely review Medicare spending and provide ...
... Survivors of the childhood cancer neuroblastoma are eight times ... to be married, and more likely to have lower ... online July 31 in the Journal of the ... because minimal information exists on the long-term outcomes for ...
Cached Medicine News:Health News:New Book by Leading Authority Responds to National Initiative to Bring Undergraduate Public Health Education to All American Colleges and Universities 2Health News:New Book by Leading Authority Responds to National Initiative to Bring Undergraduate Public Health Education to All American Colleges and Universities 3Health News: Study finds increased 'sibling risk' of obstructive sleep apnea in children 2Health News:House Tri-Committee Bill Would Hurt Patients and Kill Jobs 2Health News:House Tri-Committee Bill Would Hurt Patients and Kill Jobs 3Health News:Concord Coalition Releases Issue Brief on Administration's IMAC Proposal 2Health News:Long-term health and social outcomes for neuroblastoma survivors 2
... Autotransfusion System processes blood collected from ... red blood cells for return to ... This is achieved with only one ... bowl design, coupled with sophisticated software, ...
The Wixson Hip Positioner is used for stable positioning of a patient during total hip and revision surgery. It is designed to be placed on top of the operating table....
Stryker Instruments InterPulse System advances the ease and performance of battery powered irrigation for Orthopaedics, Trauma, and Wound Care....
... VersaNail System is a complete system of ... use with TTC fusion surgery. The system ... and integrates clinical research and engineering with ... every patient is different, and because the ...
Medicine Products: